Fred Hassan - 17 Aug 2021 Form 4 Insider Report for BridgeBio Pharma, Inc. (BBIO)

Role
Director
Signature
/s/ Barbara Bispham, Attorney-in-Fact
Issuer symbol
BBIO
Transactions as of
17 Aug 2021
Net transactions value
$0
Form type
4
Filing time
26 Aug 2021, 17:14:45 UTC
Previous filing
17 May 2021
Next filing
16 Nov 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BBIO Stock Option (right to buy) Award $0 +49,869 $0.000000 49,869 17 Aug 2021 Common Stock 49,869 $49.54 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vests and becomes exercisable in three annual installments after August 17, 2021, subject to the Reporting Person's continued service on the Issuer's Board of Directors through each such date.